Literature DB >> 17878248

Growth hormone suppression after an oral glucose load in children.

Madhusmita Misra1, Jennalee Cord, Rajani Prabhakaran, Karen K Miller, Anne Klibanski.   

Abstract

BACKGROUND: GH nonsuppression after oral glucose is diagnostic for GH excess, but normative data are lacking in children. Adult data cannot be extrapolated to children given the pubertal increase in GH concentration. In addition, because GH levels are higher in pubertal girls than boys, nadir GH may differ across gender.
OBJECTIVE: Our objective was to determine whether nadir GH during an oral glucose tolerance test (OGTT) is gender and pubertal stage specific. We hypothesized that nadir GH would be higher in girls, and at the pubertal stage known to correspond with peak height velocity (Tanner 2-3 in girls and Tanner 3-4 in boys) and maximal GH concentrations. SUBJECTS/
METHODS: A 2-h OGTT using 2.35 g/kg oral glucose (maximum 100 g) was performed in 64 girls and 43 boys, 9-17 yr (10th-90th percentiles for body mass index). Girls were grouped as group 1 (Tanner 1), group 2 (Tanner 2-3), and group 3 (Tanner 4-5), and boys as group 1 (Tanner 1-2), group 2 (Tanner 3-4), and group 3 (Tanner 5).
RESULTS: Nadir GH was higher in girls than boys, and in group 2 girls and boys than the other two groups. The upper limit for nadir GH was highest in group 2 girls (1.57 ng/ml), and lower for the other two groups of girls (0.64 ng/ml), and for boys (0.50 ng/ml). All but one girl, and all boys suppressed to less than 1.0 ng/ml. There were 16 girls and five boys who had a nadir GH of more than 0.3 ng/ml.
CONCLUSION: GH suppression after oral glucose is gender and pubertal stage specific.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17878248     DOI: 10.1210/jc.2007-1244

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

Review 1.  Effects of hypogonadism on bone metabolism in female adolescents and young adults.

Authors:  Madhusmita Misra
Journal:  Nat Rev Endocrinol       Date:  2012-01-24       Impact factor: 43.330

2.  17p13.3 microduplication including CRK leads to overgrowth and elevated growth factors: A case report.

Authors:  Rohan K Henry; Caroline Astbury; Constantine A Stratakis; Scott E Hickey
Journal:  Eur J Med Genet       Date:  2016-09-12       Impact factor: 2.708

3.  Peptide YY levels across pubertal stages and associations with growth hormone.

Authors:  Benjamin Lloyd; Praful Ravi; Nara Mendes; Anne Klibanski; Madhusmita Misra
Journal:  J Clin Endocrinol Metab       Date:  2010-04-07       Impact factor: 5.958

4.  Growth hormone is positively associated with surrogate markers of bone turnover during puberty.

Authors:  Melissa Russell; Anne Breggia; Nara Mendes; Anne Klibanski; Madhusmita Misra
Journal:  Clin Endocrinol (Oxf)       Date:  2011-10       Impact factor: 3.478

Review 5.  McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia.

Authors:  Michael T Collins; Frederick R Singer; Erica Eugster
Journal:  Orphanet J Rare Dis       Date:  2012-05-24       Impact factor: 4.123

6.  Emergence of Pituitary Adenoma in a Child during Surveillance: Clinical Challenges and the Family Members' View in an AIP Mutation-Positive Family.

Authors:  Pedro Marques; Sayka Barry; Amy Ronaldson; Arla Ogilvie; Helen L Storr; Peter J Goadsby; Michael Powell; Mary N Dang; Harvinder S Chahal; Jane Evanson; Ajith V Kumar; Joan Grieve; Márta Korbonits
Journal:  Int J Endocrinol       Date:  2018-04-04       Impact factor: 2.803

Review 7.  [The role of glucose and insulin in the metabolic regulation of growth hormone secretion].

Authors:  E L Sorkina; V V Chichkova; I A Sklyanik; M V Shestakova; G A Mel'nichenko; A Barkan
Journal:  Probl Endokrinol (Mosk)       Date:  2021-01-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.